Catherine Argyriou, PhD, discusses peroxisome disease and the development of a retinal gene therapy for PEX1-mediated Zellweger Spectrum Disorder.
This webinar provides background on peroxisomal disorders and the PEX1-G844D mouse model for mild Zellweger Spectrum Disorder, which presents with retinal degeneration and vision loss. Dr. Argyriou describes how her team used AAV8-mediated gene delivery to robustly and durably improve functional vision, retinal response, retinal structure, and biochemical metabolites in ZSD mice. Techniques used include subretinal injection, ERG, optomotor testing, histology, immunohistochemistry, and LC-MSMS. AAV vector design and validation are also discussed. This work attracted venture capital investment and is now ready to enter the clinical translation phase.
Key Topics Include:
- Introduction to peroxisome disease and the PEX1-G844D mouse model
- Application of PEX1 gene augmentation to improve retinal structure and function in transgenic mice
- Preclinical steps in retinal gene therapy development for rare disease
Presenters
Postdoctoral Fellow
Human Genetics
McGill University
Catherine’s research centers on developing drugs and gene therapies for rare disease, with a focus on retinal gene therapy to improve vision in peroxisome disorders (PBD-ZSD). She has extensive experience forming and maintaining academic and industrial collaborations, coordinating multiple project arms, directly supervising and training students/employees, and fostering relationships with patient networks.
Register
Webinar Host
Striatech
Striatech is a young biotech company that spun off from the University of Tübingen, Germany, at the beginning of 2018. The founders – a team of neurobiologists – are all experienced vision researchers and have made it their common goal to make innovative ideas and products from vision and behavioral research accessible to scientists worldwide.
Additional Content From Striatech
In Vivo Modeling of Immune-mediated Optic Neuropathies
Oliver W. Gramlich, PhD, provides an in-depth discussion about the pathobiology and visual phenotype of immune-mediated optic neuropathies.
Endothelial Caspase-9 Mediates Inflammatory and Vision Function Changes in Retinal Vascular Injury
Crystal Colón Ortiz, PhD, from the Columbia University Medical Center discusses the inflammatory role of endothelial caspase-9 in neurovascular injury and its contribution to vision changes.
Anti-FcRn Treatment in Antibody-Associated Experimental Autoimmune Encephalomyelitis
Jana Remlinger, MSc, discusses her recent research into a novel therapeutic approach for myelin oligodendrocyte glycoprotein antibody associated disorder (MOGAD).
Related Content
Multimodal Neuroimaging Using Functional Ultrasound (fUS)
Drs. Davide Boido and Antoine Bergel show how state-of-the-art multimodal neuroimaging can be coupled with functional ultrasound (fUS) to study neurovascular coupling across vigilance states.
Real-time IntraVital Microscopy (IVM): In Vivo Cellular-level Imaging of Internal Organs in a Live Animal
Join Pilhan Kim, PhD for an in-depth discussion on the All-in-One intravital two-photon and confocal microscopy system.
Developing Prefrontal Circuits and Their Role in Health and Disease
In this webinar, Dr. Ileana Hanganu-Opatz, Dr. Jastyn A. Pöpplau, and Marilena Hnida discuss their research on prefrontal networks in developing head-fixed mice, and the role of these networks in cognition and models of neurodevelopmental diseases.